Poor Science; Poorly Trained Scientists; Poor Policies: Major Deterrents to the War on Cancer
- Authors
-
-
Leslie C. Costello
School of Dentistry Department of Oncology and Diagnostic Sciences and the Greenebaum Cancer Center, University of Maryland, Baltimore, Maryland 21201, USA
-
- Keywords:
- Cancer, NIH policies, training of scientists, excessive molecular biology, holistic physiological/pathophysiological approach.
- Abstract
-
Although the availability of funding has been described as the major limitation on advances in cancer, the progress in the war on cancer has been deterred mainly by poor science, poorly trained scientists, and poor NIH policies. This is the result of NIH policies of its extreme focus on molecular biology (genomics, molecular genetics, molecular biology) identification of the molecular factors and pathways; which are required for the acceptability of treatment and preventive protocols. As such, this has influenced virtually all agencies that provide grants for medical research to adopt the NIH policies. This has impacted the funding of the research as well as the focus of the training of scientists. Directors of NCI Dr. Varmus (also Nobel Prize awardee) and Dr. Zerhouni had addressed this issue; and they rejected the necessity of molecular biology studies and information. NIH should return to the holistic physiological/pathophysiological approach to studies of cancer issues. This would provide the best approach for winning the war on cancer.
- Downloads
-
Download data is not yet available.
- References
-
Zerhouni E. The NIH roadmap. Science 2003; 332: 63-5. https://doi.org/10.1126/science.1091867
Leaf C. Why we're losing the war on cancer (and how to win it). Fortune 2004; 149(6): 76-82.
Costello LC. The effect of contemporary education and training of biomedical scientists on present and future medical research. Acad Med 2009; 84: 459-63. https://doi.org/10.1097/ACM.0b013e31819a7c6b
Perspective: Is NIH funding the "best science by the best scientists"? A critique of the NIH R01 research grant review policies. Acad Med 2010; 85(5): 775-9. https://doi.org/10.1097/ACM.0b013e3181d74256
National Institutes of Health. Enhancing Peer Review at NIH: Overview. Available at: http://enhancing-peer-review.nih.gov/index.html. Accessed January 18, 2010
Office of Extramural Research, National Institutes of Health. Encouraging Early Transition to Research Independence: Modifying the NIH New Investigator Policy to Identify Early Stage Investigators. Available at: http://grants.nih.gov/grants/guide/notice-files/NOT-OD-08-121.html. Accessed January 18, 2010.
Bernard C. An Introduction to the Study of Experimental Medicine. New York, NY: The Macmillan Company 1927.
- Downloads
- Published
- 15-08-2018
- Issue
- Vol. 7 No. 3 (2018)
- Section
- Articles
How to Cite
Similar Articles
- Giovanni Luigi Capella, Clinicopathologic Dissociation in Dermat[onc]ology – and Beyond , Journal of Cancer Research Updates: Vol. 11 (2022)
- Fabio Franceschini Mitri, Advances of the Nanotechnology in Targeted Nanomedicines for Treatment of Bone Cancers and Diseases , Journal of Cancer Research Updates: Vol. 10 (2021)
- Weiqi Zeng, Min Qi, Jianglin Zhang, Xiang Chen, NACA (Nascent-Polypeptide-Associated Complex α Subunit) Against Apoptosis in B Lymphoma Cell is Independent of β Subunit (NACB) , Journal of Cancer Research Updates: Vol. 3 No. 2 (2014)
- S. Simonida Crvenkova, Maja Popova, Concomitant Treatment for Brain Metastases in Non-Small Cell Lung Cancer Patients: Our Clinical Experience , Journal of Cancer Research Updates: Vol. 5 No. 1 (2016)
- Tatjana P. Stanojkovic, Sanja Milovic, A Marine Natural Products as Modulators of Multidrug Resistance , Journal of Cancer Research Updates: Vol. 9 No. 1 (2020)
- Leonello Tacconi, Gennaro D’Acunzi, Camilla Russo, Andrea Manto, Ginevra F. D’Onofrio, Raffaele Fristachi, About a Rare Case of Low-Grade Chondrosarcoma of the Cranial Vault , Journal of Cancer Research Updates: Vol. 7 No. 1 (2018)
- Wifaq Siam, Mona Ellaithi, Hind M. AbuShama, Abdulrahman Mujalli, Shakir Idris, Alaa Siddiq, Osama Mohamed Khair, Dania A. Albader, Faris M. Elmahdi, Clinicopathological Features and RB1 Gene Polymorphism in Sudanese Retinoblastoma Patients , Journal of Cancer Research Updates: Vol. 14 (2025)
- Zeli Huang, Jiezhan Feng, Shaoen Li, Weihong Wei, Guoyi Zhang, Qiuxia Lu, Yongfeng Wu, Li Lin, Tao Xu, Is the Neoadjuvant Docetaxel, Cisplatin and 5-Fluorouracil Regimen Superior to Classic Cisplatin and 5-Fluorouracil for Locoregionally Advanced Nasopharyngeal Carcinoma? , Journal of Cancer Research Updates: Vol. 2 No. 4 (2013)
- Ananda M. Chakrabarty, COMMENTARY: BRCA1/2 Mutations, Vulnerability to Breast/Ovarian Cancer, and Current and Future Treatment Modalities , Journal of Cancer Research Updates: Vol. 5 No. 2 (2016)
- Najia Mansoor, Rafeeq Alam Khan, Johannes Schueller, Dagmar Ettlinge, Philipp Buchner, Martin Czejka, Tasneem Ahmad, Irinotecan (CamptoR) Pharmacokinetics and Metabolism in Patients with Elevated Serum Bilirubin Levels , Journal of Cancer Research Updates: Vol. 5 No. 2 (2016)
You may also start an advanced similarity search for this article.